Israeli Expert: Fourth Dose Vaccine not Really Need for Covid-19

Three doses of the vaccine will likely provide long-term protection against Covid-19. So that the fourth dose does not really need to be injected in the near future. This is a statement from one of the Israeli health experts.

Professor Eyal Leshem, an infectious disease specialist at Sheba Medical Center predicts that in the long term the practice of injecting two or three doses of the vaccine will likely provide sufficient protection against severe disease for the majority of people.

“We may need to update the vaccine booster every few years, possibly annually, to match the common variant, but we may not need another booster if future Covid-19 variants prove to be less virulent as we saw with the Omicron variant,” he said. as quoted from CNBC International, Tuesday.

“So it’s possible that people who have been injected with two or three doses of the current vaccine, and then during this wave are exposed to omicron or are exposed to other variants in the future that are less virulent, not needing another booster at all.”

Eyal Leshem also expressed his views on the Israeli government‘s decision to inject the fourth dose of vaccine into the elderly. According to the decision was taken based on the recommendations of experts not based on existing data.

“We really have very little scientific data to suggest a fourth dose will provide a substantially increased protection against severe illness and hospitalization,” he said.

Israel is one of the countries that is quite aggressive in injecting the Covid-19 vaccine to end the Covid-19 pandemic in that country as soon as possible. Currently, 71% of Israelis have received at least one dose of the Covid-19 vaccine and 64% have received a second dose. Nearly half of Israelis have also been injected with a third dose of a booster.

This week, 136,569 people in Israel were confirmed positive for Covid-19, this figure is up 331% from the previous week. Cases of hospitalized patients have also increased but not as much as during the peak of infection with the Delta variant in Israel.